Dr David Huang is the Director of Clinical Innovation at Voy, Europe's largest digital health provider of weight management and hormonal health services, where he leads clinical strategy, evidence generation and scientific & strategic partnerships. A former NHS doctor, he recently co-authored the largest real-world study of tirzepatide in women with PMOS, and previously co-founded the first private menopause service commissioned by the NHS.